Clinical Trials Browser

Phase 2 × OTHER_GOV × niraparib × Clear all

NCT03983226 2022-03-18

Surgery and Niraparib in Secondary Recurrent Ovarian Cancer (SOC-3 Trial)

Phase 2 Recruiting

Fallopian Tube Neoplasms